At the start of EMPERIE in May 2009, the world was confronted with the first influenza pandemic of the 21st century, caused by the novel Influenza A/H1N1. Annex I of EMPERIE states “(…)EMPERIE will be fully committed to dedicate all its resources, research potential and other capabilities during the entire project time to address newly emerging infectious disease threats whenever they would occur, to the extent that such an incident will be brought under control as soon as possible”.
With the 2009 influenza pandemic clearly qualifying as a ‘newly emerged infectious disease threat’, EMPERIE started with refocusing a significant part of its resources in period 1 to influenza A/H1N1 response, in close collaboration with the European Commission. During the first months of EMPERIE, the principal investigators of the partners in EMPERIE identified a range of urgent research needs and associated research studies in response to the influenza pandemic that could be included in the EMPERIE framework that:
- Have a clear added value to the H1N1 pandemic response from a scientific and public health perspective;
- Are complementary to other ongoing initiatives by other networks and organizations (such as WHO);
- Are in line with the overall scope and objectives of the EMPERIE project.
Download Influenza 2009 pandemic response for a summary overview of the results of the work performed on the novel influenza H1N1 virus in the first year of EMPERIE.